Skip Navigation

A Phase II Pilot Study of ADP-A2M4 in Combination with Pembrolizumab for Advanced or Recurrent Head and Neck Cancer.

Brief Summary

Type:
Head and Neck Cancers

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT04044859

Study #:
STUDY00145581

Start Date:
Jul 27, 2020

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04044859

View Complete Trial Details & Eligibility at ClinicalTrials.gov